Mingtiandi

Asia real estate and outbound investment news

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
Remember Me

Lost your password?

Register Now

Loading...
  • Capital Markets
  • Events
    • Mingtiandi 2025 Event Calendar
    • Mingtiandi APAC Residential Forum 2025
    • Mingtiandi Singapore Forum 2025
    • Mingtiandi APAC Logistics Forum 2025
    • Mingtiandi APAC Data Centre Forum 2025
    • Mingtiandi Tokyo Forum 2025
    • More Events
  • MTD TV
    • Residential
    • Logistics
    • Data Centre
    • Office
    • Singapore
    • Tokyo
    • Hong Kong
    • All Videos
    • Post-Event Stories
  • People
    • Industry Moves
    • MTD TV Speakers
  • Logistics
  • Data Centres
  • Asia Outbound
  • Retail
  • Research & Policy
  • Advertise

CapitaLand Ascendas REIT ‘Pharms Out’ San Diego Office Complex

2022/10/03 by Christopher Caillavet Leave a Comment

The upgraded building will serve as the headquarters of San Diego-based Crinetics Pharmaceuticals

Singapore-listed CapitaLand Ascendas REIT plans to convert one of its California office buildings into a life science property after fully leasing the asset to a US pharmaceutical company.

The trust formerly known as Ascendas REIT will equip the San Diego building with new mechanical, electrical and plumbing systems and state-of-the-art labs, offices and vivarium spaces at an estimated cost of $40 million, CLAR’s manager said Friday in a release. The property will feature solar panels for energy efficiency and spa-like amenities for employees.

The two-storey, 94,230 square foot (8,754 square metre) building at 6055 Lusk Boulevard will serve as the global headquarters of Crinetics Pharmaceuticals, a NASDAQ-listed maker of drugs for rare endocrine diseases and related tumours.

“We are delighted to announce this partnership with Crinetics Pharmaceuticals,” said William Tay, executive director and CEO of the trust’s manager, which is wholly owned by SGX-listed CapitaLand Investment. “This initiative will have long-term benefits for both our companies.”

Future Yield Boost

The redevelopment property sits within the CareFusion campus in northwestern San Diego’s Sorrento Valley, a local hub for tech and life science firms, with Crinetics’ existing offices located just a two-minute drive away at 10222 Barnes Canyon Road.

William Tay, CEO of Ascendas REIT

William Tay of CapitaLand Ascendas REIT

The conversion to a life science space with LEED Gold certification will enable CLAR to charge a higher base rent with an annual escalation of 3 percent, while boosting net property income yield to 9 percent upon completion of the upgrade in the fourth quarter of 2023.

“This venture will solidify and enlarge CapitaLand Ascendas REIT’s track record in the life sciences space and foster even more opportunities for us,” Tay said.

CLAR took ownership of the building in 2019 as part of a $937.6 million portfolio of 28 US business park assets acquired from wholly owned entities of CapitaLand. The deal with Crinetics includes a triple-net lease commitment of 11.5 years, with an option to extend two additional five-year terms.

Choosing Life

The asset conversion is estimated to increase the proportion of CLAR’s life science properties to S$1.3 billion, or about 8 percent of assets under management. The REIT’s life science portfolio currently consists of seven Singapore properties, including the seven-storey, 497,012 square foot Nucleos biomedical research facility at the One North tech park.

At the end of June, CLAR’s S$16.6 billion ($11.6 billion) portfolio included 228 properties in Singapore, the US, Australia and Europe. Since then, the trust has announced its intention to acquire a food storage and distribution centre in western Singapore from PGIM Real Estate for S$191.9 million ($136.5 million).

Listed in November 2002, Ascendas REIT was rechristened CapitaLand Ascendas REIT last week. Also renamed were Ascott Residence Trust, which became CapitaLand Ascott Trust, and Ascendas India Trust, rebranded as CapitaLand India Trust.

Share this now

  • LinkedIn
  • Share
  • Tweet
  • Email

Filed Under: Projects Tagged With: Ascendas REIT, California, Featured, Life Sciences, weekly-sp

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Mingtiandi Delivered

  • This field is for validation purposes and should be left unchanged.

MTD TV

Pierre-Alexandre Humblot, ESR
Asset Quality, Location Key to Boosting Returns in Korea and Japan Logistics: MTD TV
value-add forum 2021-03-30
Link REIT CEO George Hongchoy Says Sustainability Key to Boosting Returns

More MTD TV Videos>>

People in the News

singh-anshuman
Asia Real Estate People in the News 2025-06-16
Raymond Lee Paul Hastings
Law Partner Picks Up Hong Kong Home of Former Birmingham City Boss for $37M
Teo Chee Hean Temasek
Asia Real Estate People in the News 2025-06-09
Lincoln Pan Jardines
Asia Real Estate People in the News 2025-06-02

More Industry Professionals>>

Latest Stories

Far East Orchard CEO Alan Tang
Singapore’s Far East Orchard Hits $130M Final Close of UK Student Housing Fund
Richard Stacker, Industrial and Logistics, CEO, Charter Hall
Rava Partners, Charter Hall, Barings to Appear in Mingtiandi Logistics Forum This Week
Momoi Hiroaki, executive director of KDX Realty
Kenedix REIT Selling Greater Osaka Mall for $41M

Sponsored Features

How to Create a Win-Win for Investors and Occupiers
Lingeage Logistics Cold Storage Complex
Mount Maunganui Cold Storage Facility for Sale
7 in 10 Senior Directors Confident in Data Centres, but Talent Shortage Will Widen

More Sponsored Features>>

Connect with Mingtiandi

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Real Estate News

  • Capital Markets
  • Mingtiandi 2025 Event Calendar
  • MTD TV Archives
  • People
  • Logistics
  • Data Centres
  • Asia Outbound
  • Retail

More Mingtiandi

  • About Mingtiandi
  • Contact Mingtiandi
  • Mingtiandi Memberships
  • Newsletter Subscription
  • Advertise
  • Terms of Use
  • Privacy
  • Join the Mingtiandi Team


© 2007-2025 China Advertising Media Ltd (Samoa). All rights reserved.

We use cookies in accordance with our Privacy policy to provide the best user experience on Mingtiandi and to safeguard user data. By continuing to browse you consent to the policy. AcceptRefuse